Arsenic levels in ground water and cancer incidence in Idaho: an ecologic study

Internationales Archiv für Arbeitsmedizin - Tập 82 Số 7 - Trang 843-849 - 2009
Yueh‐Ying Han1, Joel L. Weissfeld1, Devra Lee Davis1, Evelyn O. Talbott2
1Center for Environmental Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
2Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, A526 Crabtree Hall, Pittsburgh, PA, 15261, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ayotte JD, Baris D, Cantor KP et al (2006) Bladder cancer mortality and private well use in New England: an ecological study. J Epidemiol Community Health 60(2):168–172

Bates MN, Smith AH, Cantor KP (1995) Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol 141(6):523–530

Cancer Data Registry of Idaho (2006) Geographic Reports: County Cancer Profile [cited 09 April 2007]

Chappell WR, Beck BD, Brown KG et al (1997) Inorganic arsenic: a need and an opportunity to improve risk assessment. Environ Health Perspect 105(10):1060–1067

Focazio MJ, Welch AH, Watkins SA et al (2000) US Geological Survey. A retrospective analysis on the occurrence of arsenic in ground-water resources of the United States and limitations in drinking-water-supply characterizations. Water-resources investigations Report 99–4279. Prepared in cooperation with the US Environmental Protection Agency Office of Ground Water and Drinking Water

Forman D, Cook-Mozaffari P, Darby S et al (1987) Cancer near nuclear installations. Nature 329(6139):499–505

Gebel T (2000) Confounding variables in the environmental toxicology of arsenic. Toxicology 144(1–3):155–162

Hagan EF (2004) Idaho Department of Water Resources, ground water quality technical brief, statewide ambient ground water quality monitoring program arsenic speciation results (2002 & 2003) [cited 19 March 2007]

Hopenhayn-Rich C, Biggs ML, Smith AH (1998) Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int J Epidemiol 27(4):561–569

Howe GR (1991) Risk of cancer mortality in populations living near nuclear facilities. JAMA 265(11):1438–1439

Huang C, Ke Q, Costa M et al (2004) Molecular mechanisms of arsenic carcinogenesis. Mol Cell Biochem 255(1–2):57–66

Hughes MF (2002) Arsenic toxicity and potential mechanisms of action. Toxicol Lett 133(1):1–16

Johnson CJ, Carson SL (2000) Cancer Data Registry of Idaho, Geographic Reports: cancer trend in Idaho: 1971–1998. [cited 01 May 2007]

Johnson CJ, Mitchell TS (2007) An evaluation of potential association between arsenic concentrations in ground water and 2000–2004 cancer incidence rates in Idaho by Zip code. Cancer Data Registry of Idaho and Department of Environmental Quality. [cited 01 May 2007]

Kapaj S, Peterson H, Liber K et al (2006) Human health effects from chronic arsenic poisoning—a review. J Environ Sci Health A Tox Hazard Subst Environ Eng 41(10):2399–2428

Karagas MR, Tosteson TD, Morris JS et al (2004) Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 15(5):465–472

Kitchin KT (2001) Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol 172(3):249–261

Lamm SH, Engel A, Kruse MB et al (2004) Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 US counties and 30 years of observation. J Occup Environ Med 46(3):298–306

Lewis DR, Southwick JW, Ouellet-Hellstrom R et al (1999) Drinking water arsenic in Utah: a cohort mortality study. Environ Health Perspect 107(5):359–365

Marshall G, Ferreccio C, Yuan Y et al (2007) Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst 99(12):920–928

Meliker JR, Slotnick MJ, Avruskin GA et al (2007) Individual lifetime exposure to inorganic arsenic using a space–time information system. Int Arch Occup Environ Health 80(3):184–197

Moore LE, Lu M, Smith AH (2002) Childhood cancer incidence and arsenic exposure in drinking water in Nevada. Arch Environ Health 57(3):201–206

Neely KW (2002) Arsenic results from the statewide program, 1991–2001. [cited 08 May 2007]

Smith AH, Goycolea M, Haque R et al (1998) Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol 147(7):660–669

Steinmaus C, Yuan Y, Bates MN et al (2003) Case-control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol 158(12):1193–1201

Tapio S, Grosche B (2006) Arsenic in the aetiology of cancer. Mutat Res 612(3):215–246

Tchounwou PB, Centeno JA, Patlolla AK (2004) Arsenic toxicity, mutagenesis, and carcinogenesis—a health risk assessment and management approach. Mol Cell Biochem 255(1–2):47–55

United States Bureau of Census (2001) Cartographic Products Management Branch [03 March cited 2007]

United States Bureau of Census (2005) United States Census 2000 summary file [cited 5 May 2007]

United States Environmental Protection Agency (2001) Arsenic in drinking water. Final rule Fed Regist 66(14):7000–7010

Welch AH, A.Watkins S, Helsel DR et al (2007) US Geological Survey. Arsenic in ground-water resources of the United States. USGS Fact Sheet 063-00 2000 [cited 02 March 2007]

Wu MM, Kuo TL, Hwang YH et al (1989) Dose–response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 130(6):1123–1132

Yoshida T, Yamauchi H, Fan Sun G (2004) Chronic health effects in people exposed to arsenic via the drinking water: dose–response relationships in review. Toxicol Appl Pharmacol 198(3):243–252